Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „mild“
Suchtreffer
Begriffe & Kennungen
Brilique · 4.5 · Ticagrelor is primarily a CYP3A4 substrate and a mild inhibitor of CYP3A4. Ticagrelor is also a P-glycoprotein
Eintrag öffnenBrintellix · 4.8 · Nausea Nausea was usually mild or moderate and occurred within the first two weeks of treatment. The reactions
Eintrag öffnenBrintellix · 4.8 · Nausea Nausea was usually mild or moderate and occurred within the first two weeks of treatment. The reactions
Eintrag öffnenBrukinsa · 4.5 · 6 Mild CYP3A inhibitors
Eintrag öffnenBrukinsa · 4.5 · Mild CYP3A inhibitors
Eintrag öffnenBrukinsa · 4.5 · Simulations using fasted conditions suggested that the mild CYP3A inhibitors (e.g., cyclosporine and fluvoxami
Eintrag öffnenBrukinsa · 4.5 · Simulations using fasted conditions suggested that the mild CYP3A inhibitors (e.g., cyclosporine and fluvoxami
Eintrag öffnenBrukinsa · 4.5 · Zanubrutinib is a mild inducer of CYP3A and CYP2C19. Concomitant use of zanubrutinib can decrease the plasma c
Eintrag öffnenBrukinsa · 4.5 · Zanubrutinib is a mild inducer of CYP3A and CYP2C19. Concomitant use of zanubrutinib can decrease the plasma c
Eintrag öffnenButter mild gesäuert
Eintrag öffnenCanavan-Krankheit, milde
Eintrag öffnenCatiolanze · 4.8 · 6 Eye disorders Iris Mild to Eyelid Iritis*; Periorbital hyperpigmentati moderate oedema¥; corneal oedema*; an
Eintrag öffnenCavoley · 4.8 · 8 Reversible, mild to moderate elevations in uric acid and alkaline phosphatase, with no associated clinical e
Eintrag öffnenCegfila (previously Pegfilgrastim Mundipharma) · 4.8 · Reversible, mild to moderate elevations in uric acid and alkaline phosphatase, with no associated clinical eff
Eintrag öffnenCerdelga · 4.3 · Cerdelga is contraindicated in CYP2D6 EMs with severe hepatic impairment and in CYP2D6 EMs with mild or modera
Eintrag öffnenCerdelga · 4.5 · CYP2D6 inhibitors in EMs with mild or moderate hepatic impairment See sections 4.2, 4.3 and 4.4.
Eintrag öffnenCerdelga · 4.5 · CYP3A inhibitors in EMs with mild hepatic impairment See sections 4.2 and 4.4.
Eintrag öffnenCetrotide · 4.8 · Mild to moderate OHSS (WHO grade I or II) have been commonly reported and should be considered as an intrinsic
Eintrag öffnenCetrotide · 4.8 · Reproductive system and breast disorders Common: Mild to moderate OHSS (WHO grade I or II) can occur which is
Eintrag öffnenCholib · 4.5 · Fenofibrate and simvastatin are not inhibitors of CYP 2D6, CYP 2E1, or CYP 1A2. Fenofibrate is a mild to moder
Eintrag öffnen